[Event Report] The Meeting of Working Group 2 on Communication Approach, “The Next Actions to Ensure the Development and Implementation of Immunization and Vaccine Policies” (March 14, 2022)
date : 4/6/2022
Tags: Vaccinations
On March 14, 2022, Health and Global Policy Institute (HGPI) held a meeting of “Next Actions to Ensure the Development and Implementation of Immunization and Vaccine Policies Working Group 2 – Communication.”
Among life stages including infancy, early childhood, childhood, puberty, adolescence, adulthood, and old age, Japan’s immunization and vaccination policies have centered on infancy, early childhood, and childhood. These policies have contributed to better health and quality of life for the public. However, as demonstrated by a growing body of global scientific evidence, a life course approach to vaccination which takes every life stage into account not only helps to maintain public health, but also generates socioeconomic benefits. There is also an ongoing shift in vaccination target groups in Japan to prevent diseases like human papillomavirus (HPV) or to protect older adults from pneumococcal diseases.
At this meeting, we deepened the discussion on which communication methods are best for effective and efficient immunization and vaccination policies that reflect societal changes and meet the needs of each target group, as well as on future actions needed to address communication issues.
To prevent the potential spread of COVID-19, this meeting was held online using a remote conferencing system.
■ 2021 Advisory Board Working Group 2 (Titles omitted; in Japanese alphabetical order by last name)
Members:
- Kyoko Ama (Representative, Children and Healthcare Project)
- Mamoru Ichikawa (Visiting Scholar, Stanford University; Representative, Association of Medical Journalism; Visiting Associate Professor, School of Medicine, Hiroshima University; Manager of Fund Development and Public Policy, READYFOR, Inc.)
- Yuko Umeyama (Governance & Operational Excellence Department, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited)
- Takahiro Kinoshita (Vice Representative, Minpapi! Let’s Learn About HPV Project; Vice Representative, CoV-Navi)
- Tomoko Koike (Associate Professor, Faculty of Nursing and Medical Care/Graduate School of Health Management, Keio University)
- Aya Saitoh (Associate Professor, Department of Health Sciences, Graduate School of Health Sciences, Niigata University)
- Mikihito Tanaka (Professor, Journalism Course, Graduate School of Political Science, Waseda University; Professor, School of Political Science and Economics, Waseda University)
- Makiko Nakatani (Secretariat, KNOW VPD! Protect Our Children)
MC/Moderator:
- Joji Sugawara (Manager, Health and Global Policy Institute)
■Related contents held as part of the project
– November 4, 2021 The First Meeting of Working Group 5 on Vaccine Research and Development, “Next Actions for the Development and Implementation of Immunization and Vaccination Policies”
– January 17, 2022 The Second Meeting of Working Group 5 on Vaccine Research and Development, “The Next Actions to Ensure the Development and Implementation of Immunization and Vaccine Policies”
– March 9, 2022 The Meeting of Working Group 1 on Life Course Approach, “The Next Actions to Ensure the Development and Implementation of Immunization and Vaccine Policies”
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)